Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Weitere Titel der Reihe: Chapman & Hall/CRC Biostatistics Series
Alle anzeigenMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
sofort lieferbar
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
ca. 140.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
ca. 80.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
ca. 86.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
ca. 146.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
ca. 156.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Weitere Titel zum Thema
Probability and Statistics for Engineering and the Sciences, Loose-Leaf Version
Cengage Learning, 2026
979-8-214-02489-9
ca. 167.00 CHF
Lieferzeit unbestimmt
Introduction to Applied Spatial Econometrics
Taylor and Francis, 2027
978-1-4822-3638-5
ca. 106.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Good Manufacturing Practices for Pharmaceuticals
Taylor and Francis, 2026
978-1-041-00249-9
ca. 299.00 CHF
erscheint im Mai
Targeting Intercellular Communication with Nanomedicine and Advanced ...
Elsevier, 2026
978-0-443-34031-4
ca. 255.00 CHF
erscheint im September
Drafting Agreements in Life Sciences
Bloomsbury, 2027
978-1-5265-3241-1
ca. 769.00 CHF
erscheint im Januar
Engineered Biomaterials for Drug Delivery
Elsevier, 2026
978-0-323-95751-9
ca. 308.00 CHF
erscheint im Juli
Process Analytical Technology and Data Analysis for the Manufacturing of ...
Taylor and Francis, 2026
978-1-032-66291-6
ca. 169.00 CHF
erscheint im August
Pharmaceutical Process Engineering
Taylor and Francis, 2026
978-1-032-73011-0
ca. 315.00 CHF
erscheint im Juli
Prescriptions for Quant Traders Using R
Videos & Scripts
Taylor and Francis, 2026
978-1-032-97228-2
ca. 125.00 CHF
erscheint im April
Financial Enterprise Risk Management
Cambridge Academic, 2026
978-1-009-56555-4
ca. 165.00 CHF
erscheint im Mai
Lipid Nanoparticles-Based mRNA Delivery System
Elsevier, 2026
978-0-443-45006-8
ca. 255.00 CHF
lieferbar in ca. 10-20 Arbeitstagen

